BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 18/03/1998

FDA Releases Draft Guidance on Clinical Trials for Rheumatoid Arthritis Treatments

The Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical industry on developing clinical trials for rheumatoid arthritis (RA) treatments, including drugs, devices, and biological products. The agency is now accepting public comments on the document.

Source: Federal Register — Food and Drug AdministrationOpen original release →